Skip to main content
Veterinary Medicines

Biofel PCH raztopina za injiciranje za mačke

Authorised
  • Feline panleucopenia virus, strain FPV Bio 7, Inactivated
  • Feline calicivirus, strain F9, Live
  • Feline rhinotracheitis virus, strain FHV-1 Bio-9, Inactivated

Product identification

Medicine name:
Biofel PCH raztopina za injiciranje za mačke
Active substance:
  • Feline panleucopenia virus, strain FPV Bio 7, Inactivated
  • Feline calicivirus, strain F9, Live
  • Feline rhinotracheitis virus, strain FHV-1 Bio-9, Inactivated
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline panleucopenia virus, strain FPV Bio 7, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Feline calicivirus, strain F9, Live
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Feline rhinotracheitis virus, strain FHV-1 Bio-9, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AA04
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • NP/V/0036/001
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 3/11/2021
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."